Global Facial Injectable Market, By Type (Wrinkle Relaxers and Dermal Fillers), Applications (Facial Line Correction, Lip Augmentation, Face Lift, Acne Scar Treatment, Lip atrophy Treatment and Other Applications), End Users (Hospitals, Dermatology Clinics, Beauty Clinics, Dermatology Research Institutes and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights of Facial Injectable Market
Rising focus on the physical appearance coupled with changing lifestyle has propelled the growth of facial injectable market. Data Bridge Market Research analyses that the facial injectable market will exhibit a CAGR of around 9.85% for the forecast period of 2021-2028. This means that the current facial injectable market value, which is USD 5,599.24 million will rocket up to USD 11,872.16 million by the year 2028.
Facial injectable products are those products that are used in facial surgeries and facial rejuvenation. Facial injectable products are majorly used to reduce the signs of aging and increase aesthetic beauty. Facial injectables smoothen and lighten the scars and wrinkles on the skin.
The rising geriatric population across the globe coupled with the rising desire to work on the physical appearance is promoting the growth of the facial injectable market. Also, rising awareness regarding various cosmetic and facial surgical procedures has induced the growth in demand for facial injectables. The increasing adoption of minimally invasive surgeries has also fostered the growth of the facial injectable market. Expanding the use of soft tissue fillers is also bolstering the market growth rate. An increase in demand for combination treatments, a rise in medical tourism, and an increase in disposable income are some other facial injectable market growth determinants.
However, the side effects of undergoing cosmetic surgeries or various facial surgeries that involve the usage of facial injectables will hammer down the market growth rate. Stringent regulations imposed on facial injectables are another growth retardant for the market.
This facial injectable market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on facial injectable market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Facial Injectable Market Scope and Market Size
The facial injectable market is segmented on the basis of type, application and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the facial injectable market is segmented into computed wrinkle relaxers and dermal fillers. Wrinkle relaxers segment is further sub-segmented into botulinum toxin and poly-L-lactic acid (PLLA). Dermal fillers segmented is further sub-segmented into collagen, hyaluronic acid, fat injection, polylactic acid, polymethyl-methacrylate microspheres (PMMA), calcium hydroxylapatite and other dermal fillers.
- On the basis of applications, the facial injectable market is segmented into facial line correction, lip augmentation, face lift, acne scar treatment, lip atrophy treatment and other applications. Other applications segment is further sub-segmented into chin augmentation and earlobe rejuvenation.
- On the basis of end users, the facial injectable market is segmented into hospitals, dermatology clinics, beauty clinics, dermatology research institutes and others.
Facial Injectable Market Country Level Analysis
The facial injectable market is analysed and market size insights and trends are provided by country, type, application and end users as referenced above.
The countries covered in the facial injectable market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the facial injectable market where the U.S. is the largest contributor. This is due to rising geriatric population in the region coupled with rising demand and adoption of various surgical procedures. Regulatory framework, prevalence of sophisticated medical technology and infrastructure and favourable reimbursement policies are also promoting growth of the market in this region. However, it is Asia-Pacific region which is set to undergo the highest compound annual growth rate during the forecast period. This is because of the increased investment in healthcare infrastructure, rising population and rising awareness regarding various efficient cosmetic surgeries. Rising disposable income and increased medical tourism are some other growth determinants for this region.
The country section of the facial injectable market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
Facial injectable market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for facial injectable market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the facial injectable market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Facial Injectable Market Share Analysis
The facial injectable market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to facial injectable market.
The major players covered in the facial injectable market report are Merz Pharma, Bloomage Biotechnology Corporation Limited, Allergan, Galderma, Ipsen Pharma, Advanced Dermatology and Cosmetic Surgery., Bausch Health Companies Inc., Sanofi, Anika Therapeutics, Inc., Integra LifeSciences Corporation., Sinclair Pharma, Suneva Medical., Scivision Biotech Inc., Zimmer Biomet, Teoxane, Prollenium Medical Technologies, Merck Sharp & Dohme Corp., ColBar LifeScience Ltd., Medytox., APTOS LTD, Healux Co., LTD and Intraline among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-